Sputnik V has been developed by the Gamaleya Research Institute of
Epidemiology and Microbiology along with the Russian Direct Investment
Fund (RDIF). The vaccine has not been tested in Phase 3 or larger
clinical trials.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/safety-efficacy-main-concerns-with-russias-covid-19-vaccine-nobel-laureate-peter-doherty/articleshow/77588180.cms
No comments:
Post a Comment